The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Poster Presentation

(E) Pharmaceutical Health Care and Sciences

[27PO8-am1] Social pharmacy-2/Pharmacoepidemiology

Sun. Mar 27, 2022 9:00 AM - 10:40 AM [Room PO8] Bldgs. 1&4, 3F Passage (Bldgs. 1&4: 3F)

9:00 AM - 10:40 AM

[27PO8-am1-20] The safety of pranlukast and montelukast during the first trimester of pregnancy: a prospective, two-centered cohort study in Japan

○Shiro Hatakeyama1, Mikako Goto2, Ayaka Yamamoto1, Jiro Ogura1, Norikazu Watanabe3, Seiji Tsutsumi4, Naho Yakuwa2, Ritsuko Yamane5, Satoru Nagase3, Kunihiko Takahashi6, Rika Kosaki7, Atsuko Murashima8, Hiroaki Yamaguchi1 (1. Department of Pharmacy, Yamagata University Hospital, 2. The Japan Drug Information Institute in Pregnancy, National Center for Child Health and Development, 3. Department of Obstetrics and Gynecology, Yamagata University Faculty of Medicine, 4. Department of Obstetrics and Gynecology, Yamagata Prefecture Central Hospital, 5. Department of pharmacy, Toranomon Hospital, 6. M&D Data Science Center, Tokyo Medical and Dental University, 7. Division of Medical Genetics, National Center for Child Health and Development, 8. Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password